Free delivery for orders over € 49 
Sotya C+E Selenium Antioxidant 100 Tablets
Sotya C+E Selenium Antioxidant 100 Tablets
Description
SOTYA C+E SELENIUM antioxidant is a dietary supplement in tablet form containing vitamin C, vitamin E, and selenium. These ingredients are known for their antioxidant properties, which help protect cells from oxidative stress caused by free radicals. This product is used to strengthen the immune system, improve skin health, and promote healthy aging.
Instructions for use
The recommended use for this product is to take 1 tablet daily, preferably with a meal. It is recommended to follow this daily dosage unless otherwise advised by a healthcare professional.
Ingredients
The main active ingredient in this product is selenium.
Nutritional Value
Features
| Product code | 692317 |
| Category | Vitamin C, Vitamins and Minerals |
| Brand | Sotya |
| Quantity | 100 |
| Product type | Tablets |
| Delivery from | Spain |
Sotya C+E Selenium Antioxidant 100 Tablets
Sotya C+E Selenium Antioxidant 100 Tablets
By
Sotya
Delivery to Luxembourg from Spain
Spain 
Out of stock
We miss this item too 😢
Leave your email, and we’ll let you know as soon as it’s back in stock!
Leave your email, and we’ll let you know as soon as it’s back in stock!
I agree to receive notifications about this item and similar products
Recently viewed products
Similar products
More products
Premium Vitamin C with pomegranate, bioflavonoids and resveratrol 1000 mg, 60 + 30 capsules, Zenyth
Vitamin C Premium 1000 mg with pomegranate, bioflavonoids and resveratrol, 60 capsules, Zenyth
Zenyth Premium Vitamin C with Pomegranate, Bioflavonoids and Resveratrol, 30 capsules
Reviews
Sotya C+E Selenium Antioxidant 100 Tablets
Earn € 1 Reward for every review
- For each submitted and approved review you can earn € 1 Reward on your Rewards Credit.
- Rewards are given once for each purchased product you have reviewed.
- You have to be authorised to receive Rewards
All reviews
There are no reviews for this product.
Thank you for your review! It has been sent for moderation.
Description 
